Divi's Laboratories Ltd 2018 AR2
The report highlights Divi's Laboratories Limited's financial and operational performance for the fiscal year 2017-18, emphasizing its commitment to sustainable chemistry and community development. The company invested 16.98 crores in Corporate Social Responsibility (CSR) initiatives, focusing on education, preventive healthcare, safe drinking water, and rural development. Operationally, Divi's successfully resolved US-FDA regulatory issues at its Unit-II facility, leading to the lifting of the import alert and warning letter. The company continues to prioritize green chemistry principles, waste recycling, and energy conservation across its manufacturing facilities.
Company: Divi's Laboratories Ltd
Sector: Manufacturing
Country: India
Year: 2018
Type: AR2
Pages: 204
Back to company
Divi's Laboratories Ltd
Annual Report
The report highlights Divi's Laboratories Limited's financial and operational performance for the fiscal year 2017-18, emphasizing its commitment to sustainable chemistry and community development. The company invested 16.98 crores in Corporate Social Responsibility (CSR) initiatives, focusing on education, preventive healthcare, safe drinking water, and rural development. Operationally, Divi's successfully resolved US-FDA regulatory issues at its Unit-II facility, leading to the lifting of the import alert and warning letter. The company continues to prioritize green chemistry principles, waste recycling, and energy conservation across its manufacturing facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2018
Published
Sep 10, 2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees